Cerus's (CERS) Outlook - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Cerus Corporation  (NASDAQ: CERS)
 



  Cerus Corporation Outlook

On January 13 2025 the Cerus Corporation provided following guidance

nnCerus Corporation Issues Preliminary Product Revenue Estimates for Q4 and Full-Year 2024, Along with 2025 Business Outlooknn

Cerus Corporation, a leader in the field of blood safety and pathogen inactivation, has announced its preliminary product revenue for the fourth quarter and the entirety of 2024, along with a forward-looking guidance for 2025. The company projects that its total product revenue for the full year 2024 will reach approximately $180.3 million. This figure notably surpasses the company’s previous guidance, which anticipated revenue in the range of $177 million to $179 million.

In detailing the revenue for 2024, the company has highlighted that included within this total is $9.2 million generated from its Intercept Blood System for platelet and plasma products (referred to as IFC revenue). This robust performance reflects the ongoing demand for Cerus’ innovative products and its strong position in the blood safety marketplace.

While the company is optimistic about its performance in 2024, it has also provided a glimpse into its expectations for 2025. Although specific revenue projections for the upcoming year have not been disclosed, the guidance indicates a continued focus on growth and a potential for expanded product offerings in the years to come.

Cerus Corporation operates out of Concord, California, and is publicly traded on the NASDAQ under the ticker symbol CERS. The robust results for 2024 underline the company's commitment to enhancing blood safety through its advanced technology and its efforts to capture a larger share of the market going forward.,





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.